Examples of using Immunotherapy in English and their translations into Chinese
{-}
-
Political
-
Ecclesiastic
-
Programming
The most well-known application is Cancer Immunotherapy where the immune system is used to treat cancer.
Immunotherapy is also often used in the immunosuppressed(such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases.
Emerging research data suggest that immunotherapy, specifically PD-1 blockade, may play a role in the treatment of recurrent Hodgkin lymphoma.
To begin uncovering the rules of immunotherapy, the team turned to a set of three tools.
For example, antibodies blocking TGF beta could potentially be used in combination with conventional immunotherapy drugs to overcome the resistance problem.
Not every person who has a cancer with increased PD-L1 will respond to the immunotherapy, however, and your response may change over time.
Some types of immunotherapy have been shown to be effective in combating cancers, but they can also come with unwanted side effects.
Cancer immunotherapy aims to enhance or restore the ability of the patient's immune system- namely T cells- to recognize and attack cancer.
Treatment options can include traditional chemotherapy, immunotherapy(such as using antibodies or immune modulating drugs), and even radiation.".
Cancer immunotherapy- efforts to better arm a patient's own immune system to attack tumors- has shown great potential for treating some cancers.
And the researchers found immunotherapy could be effective at preventing relapse, by getting the body's immune response back on track.
Juno's advanced cellular immunotherapy portfolio and research capabilities strengthen Celgene's global leadership in hematology and adds new drivers for growth beyond 2020.
Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.
In the trial, compared with chemotherapy, the immunotherapy drug improved survival in all patients whose tumors express a protein called PD-L1.
One of the breakaway innovations, immunotherapy, introduced a new treatment option beyond the traditional methods of radiation, chemotherapy, and surgery.
While clinically active alone, oncolytic immunotherapy may have synergy with certain other treatments and, in particular, with immune checkpoint blockade therapies.
For example, in July 2015, Chinese-owned Merck acquired cCam Biotherapeutics, an Israeli cancer immunotherapy company, for 605 million USD.
He describes it as"an important step" toward expanding"the number of people who benefit from immunotherapy.".
This is a completely new form of immunotherapy,” says Sidi Chen, assistant professor of genetics and senior author of the study.
Their findings, for example, could serve to open immunotherapy options for up to 38% of gastric cancer patients.